| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YMTHE.2020.11.007 |
| P698 | PubMed publication ID | 33186691 |
| P50 | author | Carl H. June | Q19277113 |
| Simon F Lacey | Q56978267 | ||
| Bruce L. Levine | Q85544154 | ||
| P2093 | author name string | Fang Chen | |
| Dong H Lee | |||
| Jeffrey M Jacobson | |||
| Wei-Ting Hwang | |||
| Irina Kulikovskaya | |||
| Julie K Jadlowsky | |||
| Joseph A Fraietta | |||
| Gabriela Plesa | |||
| Hideto Chono | |||
| Alexander Dimitri | |||
| Chelsie Bartoszek | |||
| Elizabeth A Veloso | |||
| P2860 | cites work | Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV | Q28235281 |
| CD4(+) T Cells Modified by the Endoribonuclease MazF Are Safe and Can Persist in SHIV-infected Rhesus Macaques | Q28656393 | ||
| In vivo safety and persistence of endoribonuclease gene-transduced CD4+ T cells in cynomolgus macaques for HIV-1 gene therapy model | Q28741350 | ||
| Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases | Q29615069 | ||
| RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma | Q34121209 | ||
| Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells | Q35202343 | ||
| HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression | Q36781531 | ||
| Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys | Q37295534 | ||
| An efficient large-scale retroviral transduction method involving preloading the vector into a RetroNectin-coated bag with low-temperature shaking | Q39031463 | ||
| Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells | Q39188427 | ||
| Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interferase | Q39677452 | ||
| Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor | Q41410840 | ||
| A bioassay for HIV-1 based on Env-CD4 interaction | Q41717006 | ||
| Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor. | Q41918232 | ||
| Expression and characterization of the trans-activator of HTLV-III/LAV virus | Q45831293 | ||
| Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients | Q45875400 | ||
| Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics | Q57282212 | ||
| Re-emergence of HIV after stopping therapy | Q59060012 | ||
| In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activity | Q91164201 | ||
| P577 | publication date | 2020-11-10 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals |
Search more.